Abbott Laboratories (ABT) Q1 2021 Earnings Results

Abbott Labs Misses on EPS, Stock Down 3.64%

Abbott Labs reported a slight miss on EPS, which contributed to a 3.64% decline in stock price following the earnings announcement. The lack of revenue data and guidance updates may have added to investor uncertainty. Management's cautious tone suggests they are navigating challenges but remain focused on future growth opportunities.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.32	N/A	-0.98%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management acknowledged the current difficulties while emphasizing their commitment to strategic initiatives. They remain focused on long-term goals despite short-term setbacks.

Management noted ongoing challenges but expressed confidence in long-term growth.

They highlighted the importance of innovation in driving future performance.

Abbott Labs Misses on EPS, Stock Down 3.64%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Misses on EPS, Stock Down 3.64%

Key numbers

Management commentary